WVE logo

Wave Life Sciences Ltd. (WVE) Cash From Operations

Annual CFO:

-$151.03M-$131.59M(-677.24%)
December 31, 2024

Summary

  • As of today, WVE annual cash from operations is -$151.03 million, with the most recent change of -$131.59 million (-677.24%) on December 31, 2024.
  • During the last 3 years, WVE annual cash from operations has fallen by -$62.03 million (-69.71%).
  • WVE annual cash from operations is now -4153.06% below its all-time high of -$3.55 million, reached on December 31, 2013.

Performance

WVE Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEcash flow metrics

Quarterly CFO:

-$48.00M+$15.04M(+23.86%)
June 30, 2025

Summary

  • As of today, WVE quarterly cash from operations is -$48.00 million, with the most recent change of +$15.04 million (+23.86%) on June 30, 2025.
  • Over the past year, WVE quarterly cash from operations has dropped by -$20.82 million (-76.58%).
  • WVE quarterly cash from operations is now -156.13% below its all-time high of $85.52 million, reached on March 31, 2023.

Performance

WVE Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEcash flow metrics

TTM CFO:

-$201.93M-$20.82M(-11.49%)
June 30, 2025

Summary

  • As of today, WVE TTM cash from operations is -$201.93 million, with the most recent change of -$20.82 million (-11.49%) on June 30, 2025.
  • Over the past year, WVE TTM cash from operations has dropped by -$73.85 million (-57.66%).
  • WVE TTM cash from operations is now -12380.12% below its all-time high of -$1.62 million, reached on March 31, 2023.

Performance

WVE TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherWVEcash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

WVE Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-677.2%-76.6%-57.7%
3Y3 Years-69.7%-70.3%-97.2%
5Y5 Years+19.8%-27.8%-36.8%

WVE Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-677.2%at low-156.1%+23.9%>-9999.0%at low
5Y5-Year-677.2%+19.8%-156.1%+23.9%>-9999.0%at low
All-TimeAll-Time-4153.1%+19.8%-156.1%+23.9%>-9999.0%at low

WVE Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
-$48.00M(+23.9%)
-$201.93M(-11.5%)
Mar 2025
-
-$63.04M(-47.6%)
-$181.11M(-19.5%)
Dec 2024
-$151.03M(-677.2%)
-$42.71M(+11.4%)
-$151.50M(-6.8%)
Sep 2024
-
-$48.18M(-77.3%)
-$141.85M(-10.8%)
Jun 2024
-
-$27.18M(+18.7%)
-$128.08M(+7.4%)
Mar 2024
-
-$33.43M(-1.1%)
-$138.28M(-615.4%)
Dec 2023
-$19.43M(+84.8%)
-$33.06M(+3.9%)
-$19.33M(+5.7%)
Sep 2023
-
-$34.41M(+8.0%)
-$20.49M(-89.3%)
Jun 2023
-
-$37.39M(-143.7%)
-$10.82M(-568.9%)
Mar 2023
-
$85.52M(+349.9%)
-$1.62M(+98.7%)
Dec 2022
-$127.78M(-43.6%)
-$34.22M(-38.3%)
-$127.01M(-27.3%)
Sep 2022
-
-$24.74M(+12.2%)
-$99.80M(+2.5%)
Jun 2022
-
-$28.18M(+29.3%)
-$102.39M(-22.5%)
Mar 2022
-
-$39.87M(-469.1%)
-$83.62M(+5.1%)
Dec 2021
-$88.99M(+23.3%)
-$7.01M(+74.4%)
-$88.12M(+23.1%)
Sep 2021
-
-$27.34M(-190.6%)
-$114.59M(-5.3%)
Jun 2021
-
-$9.41M(+78.8%)
-$108.79M(+20.6%)
Mar 2021
-
-$44.38M(-32.6%)
-$136.95M(-15.3%)
Dec 2020
-$115.98M(+38.4%)
-$33.47M(-55.4%)
-$118.82M(+19.5%)
Sep 2020
-
-$21.54M(+42.7%)
-$147.63M(+12.7%)
Jun 2020
-
-$37.57M(-43.1%)
-$169.13M(-3.0%)
Mar 2020
-
-$26.25M(+57.9%)
-$164.23M(+12.8%)
DateAnnualQuarterlyTTM
Dec 2019
-$188.23M(-723.3%)
-$62.28M(-44.7%)
-$188.36M(-19.0%)
Sep 2019
-
-$43.03M(-31.7%)
-$158.28M(-9.7%)
Jun 2019
-
-$32.67M(+35.2%)
-$144.22M(-257.1%)
Mar 2019
-
-$50.38M(-56.5%)
-$40.39M(-80.0%)
Dec 2018
-$22.86M(+72.7%)
-$32.20M(-11.1%)
-$22.43M(-70.8%)
Sep 2018
-
-$28.97M(-140.7%)
-$13.13M(-50.4%)
Jun 2018
-
$71.16M(+319.5%)
-$8.73M(+91.3%)
Mar 2018
-
-$32.43M(-41.6%)
-$100.30M(-17.6%)
Dec 2017
-$83.67M(-162.1%)
-$22.90M(+6.8%)
-$85.30M(-14.2%)
Sep 2017
-
-$24.57M(-20.4%)
-$74.71M(-20.2%)
Jun 2017
-
-$20.41M(-17.2%)
-$62.16M(-49.9%)
Mar 2017
-
-$17.42M(-41.5%)
-$41.47M(-33.0%)
Dec 2016
-$31.93M(-154.8%)
-$12.31M(-2.4%)
-$31.19M(-22.8%)
Sep 2016
-
-$12.02M(-4390.0%)
-$25.39M(-56.6%)
Jun 2016
-
$280.30K(+103.9%)
-$16.22M(+9.3%)
Mar 2016
-
-$7.14M(-9.6%)
-$17.89M(-44.6%)
Dec 2015
-$12.53M(-183.0%)
-$6.51M(-128.7%)
-$12.37M(-111.2%)
Sep 2015
-
-$2.85M(-104.6%)
-$5.86M(-94.6%)
Jun 2015
-
-$1.39M(+14.0%)
-$3.01M(-86.0%)
Mar 2015
-
-$1.62M
-$1.62M
Dec 2014
-$4.43M(-24.6%)
-
-
Dec 2013
-$3.55M
-
-

FAQ

  • What is Wave Life Sciences Ltd. annual cash from operations?
  • What is the all-time high annual cash from operations for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. annual cash from operations year-on-year change?
  • What is Wave Life Sciences Ltd. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. quarterly cash from operations year-on-year change?
  • What is Wave Life Sciences Ltd. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Wave Life Sciences Ltd.?
  • What is Wave Life Sciences Ltd. TTM cash from operations year-on-year change?

What is Wave Life Sciences Ltd. annual cash from operations?

The current annual cash from operations of WVE is -$151.03M

What is the all-time high annual cash from operations for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high annual cash from operations is -$3.55M

What is Wave Life Sciences Ltd. annual cash from operations year-on-year change?

Over the past year, WVE annual cash from operations has changed by -$131.59M (-677.24%)

What is Wave Life Sciences Ltd. quarterly cash from operations?

The current quarterly cash from operations of WVE is -$48.00M

What is the all-time high quarterly cash from operations for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high quarterly cash from operations is $85.52M

What is Wave Life Sciences Ltd. quarterly cash from operations year-on-year change?

Over the past year, WVE quarterly cash from operations has changed by -$20.82M (-76.58%)

What is Wave Life Sciences Ltd. TTM cash from operations?

The current TTM cash from operations of WVE is -$201.93M

What is the all-time high TTM cash from operations for Wave Life Sciences Ltd.?

Wave Life Sciences Ltd. all-time high TTM cash from operations is -$1.62M

What is Wave Life Sciences Ltd. TTM cash from operations year-on-year change?

Over the past year, WVE TTM cash from operations has changed by -$73.85M (-57.66%)
On this page